Hematopoietic Stem Cell Transplantation in a Very High Risk Group of Patients with the Support of Granulocyte Transfusion

被引:0
|
作者
İdil Yenicesu
Gülsan Sucak
Günter Dilsiz
Şahika Zeynep Akı
Zeynep Arzu Yeğin
机构
[1] Gazi University,Faculty of Medicine, Pediatric Hematology and Blood Bank
[2] Gazi University,Faculty of Medicine, Adult Hematology and Stem Cell Transplantation Unit
[3] Kara Elmas University,Faculty of Medicine, Family Medicine Department
来源
Indian Journal of Hematology and Blood Transfusion | 2011年 / 27卷
关键词
Stem cell transplantation; Granulocyte transfusion; Fungal infection; Anti-fungal treatment;
D O I
暂无
中图分类号
学科分类号
摘要
High risk patients with active fungal infection who had undergone hematopoietic stem cell transplantation (HSCT) with the support of granulocyte transfusions (GTX) as an adjunct to antifungal agents are reviewed retrospectively. Patients requiring immediate allogeneic HSCT for their primary hematological disorders (two severe aplastic anemia, one T cell acute lymphoblastic leukemia (ALL) in second complete remission, one acute myeloid leukemia (AML)-in first complete remission, one T-ALL in refractory relapse) but were denied by other transplant programs due to active invasive fungal infections had undergone HSCT with the support of GTX at the stem cell transplantation unit of Gazi University. Five patients who had undergone six transplants were included in the study and received a total of 38 (3–13) granulocyte transfusions during these six transplants. The median granulocyte concentration was 3.4 × 1011 per apheresis bag. Full clinical and radiological recovery was achieved in three of the five high risk patients with active invasive fungal infection with the combination of antifungal agents and GTX. Even a very high risk patient with aplastic anemia who had undergone two consecutive transplants due to secondary graft failure was also cured of his primary disease despite the presence of multiple pulmonary fungus balls. Three of the five patients with very high risk features due to the underlying hematological disease and the associated active fungal infection were rescued with allogeneic HSCT performed with the support of GTX combined with antifungal agents. Despite the limitations of this report due to its retrospective nature, it suggests that GTX might be an alternative in patients with active fungal infections who otherwise are denied by the transplant programs. However, prospective randomized studies are required to draw a solid conclusion regarding the role of GTX in HSCT recipients in desperate situations such as active fungal infections.
引用
收藏
页码:146 / 151
页数:5
相关论文
共 50 条
  • [41] Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation
    Pilar Solves
    Jaime Sanz
    Carmen Freiria
    Marta Santiago
    Ana Villalba
    Inés Gómez
    Pau Montesinos
    Juan Montoro
    Jose Luis Piñana
    José Ignacio Lorenzo
    Nieves Puig
    Guillermo F Sanz
    Miguel Ángel Sanz
    Nelly Carpio
    Annals of Hematology, 2018, 97 : 161 - 167
  • [42] The investigation of platelet transfusion refractory in 69 malignant patients undergoing hematopoietic stem cell transplantation
    Li, Guining
    Liu, Feng
    Mao, Xiaolu
    Ho, Lihua
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 45 (01) : 21 - 24
  • [44] TRANSFUSION THERAPY IN THE PATIENT UNDERGOING HEMATOPOIETIC STEM-CELL TRANSPLANTATION
    FRIEDBERG, RC
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1994, 8 (06) : 1105 - 1116
  • [45] TRANSFUSION OF RED CELLS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION: THE TRIST STUDY
    Tay, J.
    Tinmouth, A.
    Fergusson, D.
    Allan, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S323 - S324
  • [46] Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation
    O'Donghaile, Diarmaid
    Kelley, Walter
    Klein, Harvey G.
    Flegel, Willy A.
    TRANSFUSION, 2012, 52 (02) : 456 - 458
  • [47] TP53 and Complex Karyotype Represent a Very High-Risk Group in Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation: An International Collaborative Analysis
    Gagelmann, Nico
    Badbaran, Anita
    Salit, Rachel Beth
    Schroeder, Thomas
    Gurnari, Carmelo
    Pagliuca, Simona
    Ganser, Arnold
    Rautenberg, Christina
    Cassinat, Bruno
    Thol, Felicitas R.
    Wolschke, Christine
    Robin, Marie
    Heuser, Michael
    Rubio, Marie Therese
    Maciejewski, Jaroslaw P.
    Reinhardt, Hans Christian
    Scott, Bart L.
    Kroeger, Nicolaus
    BLOOD, 2022, 140
  • [48] Transfusion Support For a New Autologous Hematopoietic Stem Cell Transplant Program
    Gellner, S. Hidalgo
    Gau, N.
    TRANSFUSION, 2024, 64 : 327A - 327A
  • [49] Clinical impacts of total parenteral nutrition in hematopoietic stem cell transplantation patients with high nutritional risk
    Yang, Le
    Wu, Di
    Dai, Junting
    Lv, Huiyi
    Li, Miao
    FRONTIERS IN NUTRITION, 2024, 11
  • [50] Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Young and High-Risk Multiple Myeloma Patients
    Pan, Pan
    Jiang, Erlie
    Pang, Aiming
    BLOOD, 2023, 142